Clinical Trial Applications - Approved: Filter, Search, and view applications


Clear
Extended search...

Page 54 of 59, showing 10 Applications out of 584 total, starting on record 531, ending on 540

# Protocol No Study Title Investigator(s) & Site(s) Date Approved

531.

ECCT/17/08/05   Phase I Safety and Pharmacokinetic Study of Maraviroc in HIV-1-Exposed Infants at Risk of Acquiring HIV-1 Infection.
    Phase I Safety and Pharmacokinetic Study of Maraviroc in HIV-1-Exposed Infants at Risk of Acquiring HIV-1 Infection.   
Principal Investigator(s)
1. Isaac Tsikhutsu
Site(s) in Kenya
Kenya Medical Research Institute/Walter Reed Project HIV Program, Kericho
 
12-10-2017 View

532.

ECCT/16/05/03   Clinical trial of neem & coconut oils for tungiasis
    Phase IIA, randomised controlled trial of a locally-made, herbal remedy (neem & coconut oil) for treatment of jiggers (Tunga penetrans)   
Principal Investigator(s)
1. Ulrike Fillinger
Site(s) in Kenya
Dabaso Tujengane CBO
 
28-03-2017 View

533.

ECCT/23/10/03   PEARL RSVt Vaccine Study
    Phase III, randomized, observer-blind, placebo-controlled, multi-center, multinational study to evaluate the efficacy, immunogenicity, and safety of a Respiratory Syncytial Virus vaccine in infants and toddlers (PEARL)   
Principal Investigator(s)
1. Dr. Lucas Tina, Otieno
2. Prof. Kariuki Simon
3. Dr. Janet Nyawira Oyieko
4. Walter Otieno
5. Onono Dr. Marciana
6. Prof. Walter Jaoko
7. Dr Fredrick Sawe
Site(s) in Kenya
1. Victoria Biomedical Research Institute (VIBRI) (Kisumu county)
2. Walter Reed Army Institute of Research -Kericho Site (Kericho county)
3. KEMRI CCR – Butere Clinical Research Centre (Kakamega county)
4. Siaya County Referral Hospital (SCRH (Siaya county)
5. Kenya Medical Research Institute Center for Microbiology Research (CMR (Kisumu county)
6. KAVI - Institute of Clinical Research (KAVI - ICR) (Nairobi City county)
7. Kombewa Clinical Research Center, KEMRI, (Kisumu county)
 
12-03-2024 View

534.

ECCT/23/12/02   PEARL RSVt Vaccine Study
    Phase III, randomized, observer-blind, placebo-controlled, multi-center, multinational study to evaluate the efficacy, immunogenicity, and safety of a Respiratory Syncytial Virus vaccine in infants and toddlers (PEARL)   
Principal Investigator(s)
1. Dr. Maricianah Onono
Site(s) in Kenya
1. Victoria Biomedical Research Institute (VIBRI) (Kisumu county)
2. Walter Reed Army Institute of Research -Kericho Site (Kericho county)
3. KEMRI CCR – Butere Clinical Research Centre (Kakamega county)
4. Siaya County Referral Hospital (SCRH) (Siaya county)
5. Kenya Medical Research Institute Center for Microbiology Research (CMR) (Kisumu county)
6. KAVI - Institute of Clinical Research (KAVI - ICR) (Nairobi City county)
7. Kombewa Clinical Research Center, KEMRI, (Kisumu county)
 
10-05-2024 View

535.

ECCT/25/06/03   ZHR-001
    Physiological and Biomarker Monitoring: Enhancing Vital Signs and Biomarkers Algorithm of Binah.AI in the Kenyan Population   
Principal Investigator(s)
1. Borna Achieng Nyaoke
Site(s) in Kenya
Zuri Health Medical Centre
 
21-11-2025 View

536.

ECCT/20/02/01   Pharm PrEP for AGYW
    Pilot evaluation of pharmacy-based pre-exposure prophylaxis (PrEP) delivery   
Principal Investigator(s)
1. Prof. Elizabeth Ann Bukusi
Site(s) in Kenya
KEMRI/CMR/RCTP Kisumu-Lumumba Sub-County Hospital
 
23-03-2020 View

537.

ECCT/21/09/06   The PrEDIRA Study
    PILOTING HIV PRE-EXPOSURE PROPHYLAXIS (PREP) INTEGRATION INTO SERVICES FOR EARLY PREGNANCY LOSS   
Principal Investigator(s)
1. Prof. Elizabeth Bukusi
2. Dr. Nelly Mugo
3. Renee Heffron
Site(s) in Kenya
1. KEMRI RCTP (Kisumu county)
2. PARTNERS IN HEALTH RESEARCH AND DEVELOPMENT - THIKA (Kiambu county)
 
10-11-2021 View

538.

ECCT/15/04/02  
    Plasma concentration profiles after oral  administration of oleylphosphocholine tablet  formulation: safety, tolerability and pharmacokinetics  of 100 mg single dose in healthy male volunteers.   
Principal Investigator(s)
1. Ravasco Rashid Juma
Site(s) in Kenya
KEMRI
 
15-06-2015 View

539.

ECCT/14/07/01  
    POST STABILIZATION VERSUS URGENT START OF HAART IN HIV-1 INFECTED CHILDREN WITH SEVERE COINFECTION   
Principal Investigator(s)
1. Grace John-Stewart
Site(s) in Kenya
1. Kenyatta National Hospital (Nairobi City county)
2. Jaramogi Odinga Teaching and Referral Hospital (Kisumu county)
3. Kisumu East District Hospital (Kisumu county)
 
21-10-2014 View

540.

ECCT/19/11/02   PrEP and dPEP
    PrEP and dPEP: Doxycycline post-exposure prophylaxis for prevention of sexually transmitted infections among Kenyan women using HIV pre-exposure prophylaxis   
Principal Investigator(s)
1. Dr.Elizabeth Bukusi Ann Bukusi
Site(s) in Kenya
KEMRI/CMR/RCTP Kisumu-Lumumba Sub-County Hospital
 
31-01-2020 View